Curing Psoriasis

The presentation focuses on potential strategies for curing psoriasis, emphasizing optimism about future advancements within the speaker's lifetime. Highlighting the importance of early intervention, the speaker advocates for aggressive treatment of newly diagnosed patients to prevent chronic disease. Various novel treatment methods are discussed, including high-dose biologics and innovative therapies like CAR T-cell therapy and gene editing. A major study, the "Knockout Study," which involves increasing the dosage of IL-23 inhibitors, showed promising results with up to 83% of patients achieving complete clearance of psoriasis. The effectiveness of these treatments appears to last longer in patients with a shorter disease duration, suggesting that targeting the disease early may lead to lasting remission. Additionally, the role of resident memory T cells in psoriasis flare-ups is examined, leading to a proposal for therapies that aim to eliminate these memory cells. Other advanced options, such as mesenchymal stem cell therapy to enhance regulatory T cell function and CRISPR technology to genetically edit susceptibility to psoriasis, are also introduced. The speaker concludes by reiterating the potential for significant breakthroughs in the treatment and possible cure of psoriasis through these innovative approaches.